C4 Therapeutics cuts staff, restructures to focus on lead protein degradation programs, discovery pacts
With Phase I data on its top degrader candidates in sight, C4 Therapeutics is letting go of 45 staffers — or 30% of the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
